Abstract
The most common treatment for patients with early-stage (stage I–II) Hodgkin's lymphoma is two to four cycles of chemotherapy followed by involved-field radiation therapy.1 The long-term disease-free survival rates (ie, cure) for early-stage Hodgkin's lymphoma are 90–95%. Given the high cure rate, and bearing in mind that most patients diagnosed with Hodgkin's lymphoma are under 40 years, quality of survivorship is an important consideration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
